BridgeBio Pharma Stock News & Updates
[WKN: A2PLX7 | Symbol: BBIO]
BridgeBio Pharma
Top 5 Biopharma Stocks for the new Health era
Analysts' Top 5 Price Targets of September 1, 2025
Teamviewer [DE000A2YN900] Bank of America upgrades rating from Underperform to Buy and raises...
BridgeBio in Focus: Diversification as a Recipe for Success in the Fight Against Genetic Defects
BridgeBio Pharma is a biotechnology company focused on the discovery, development, testing, and provision...
Analysts' Top 5 Price Targets of July 14, 2025
Harrow Inc. [US4158581094] Cantor Fitzgerald starts coverage with Overweight and a price target of...
Analysts' Top 5 Price Targets of April 15, 2025
Puma [DE0006969603]: Berenberg initiates coverage with a Buy rating and a price target of €40 (100%...
BridgeBio Pharma is a Biotech Stock With Strong Potential Thanks to an Innovative Approach in Precision Medicine. Redburn Atlantic Sees Over 40% Upside Potential.
The biotech stock of BridgeBio Pharma (BBIO) has held up remarkably well in recent weeks. BridgeBio...
BridgeBio Pharma: Unrivaled Heart Medication Generates Record Revenues
Genetic disorders are generally considered rare diseases, but when they do occur, they are usually associated...
- ‹
- 1
- ›